Importantly, combining a JNK inhibitor with a BRAF inhibitor was able to overcome MAPK inhibitor resistance, as demonstrated by decreased cell migration and increased cell death compared to melanoma cells when treated with a BRAF inhibitor alone [23]. Here, BRAF is linked to melanoma.